Olema terminates ATM prospectus; no further sales until new filing

Olema Pharmaceuticals, Inc.

Terminated ATM prospectus effective November 18, 2025.
Sales Agreement with TD Securities dated January 6, 2025 remains in force.
No further sales of common stock under the ATM until new prospectus filed.
Olema had not disclosed any sales under the prior ATM; no amounts given.
Move may indicate intent to file updated prospectus or reduce equity dilution.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.